I understand his and your point of view. I don’t agree. If the hold is lifted, what happens then? It means CYDY can proceed with clinical trials. There is no guarantee that the year(s) of clinical trials subsequent to the hold being lifted will result in Leronlimab being approved by the FDA, though my opinion is that its proven efficacy thus far will result in approval. The hold being lifted has no cash value per se, though it might be helpful in establishing that Amarex’s actions caused the delay. However, there is ALREADY ample evidence that Amarex did not file the FDA submissions at a professional level, as stated by the independent auditors and the FDA itself.

Are you suggesting that the arbitration is going to be delayed until such time as Leronlimab is approved, so that damages to the penny can be established? I completely disagree. CYDY is not going to wait years for a settlement. The arbitration is not going to be delayed for years until clinical trials are completed. It is in CYDY’s best interests for the arbitration to be concluded as soon as possible, and it’s in Amarex’s best interests to drag it on as long as possible. Any finding of Amarex behaving improperly will hurt or kill their business, so they will want as much time as possible to lock other suckers, excuse me, small biotechs, into long-term contracts.